Evaluation of rat striatal l-dopa and DA concentration after intraperitoneal administration of l-dopa prodrugs in liposomal formulations-Reference-Cited by-同舟云学术

Evaluation of rat striatal l-dopa and DA concentration after intraperitoneal administration of l-dopa prodrugs in liposomal formulations

Published:2004-09 Issue:2 Volume:99 Page:293-300
ISSN:0168-3659
Container-title:Journal of Controlled Release
language:en
Short-container-title:Journal of Controlled Release

Author:

Di Stefano Antonio,Carafa Maria,Sozio Piera,Pinnen Francesco,Braghiroli Daniela,Orlando Giustino,Cannazza Giuseppe,Ricciutelli Massimo,Marianecci Carlotta,Santucci Eleonora

Publisher

Elsevier BV

Subject

Pharmaceutical Science

Reference21 articles.

1. Manganese increases l-DOPA auto-oxidation in the striatum of the freely moving rat: potential implications to l-DOPA long-term therapy of Parkinson's disease;Serra;Br. J. Pharmacol.,2000

2. History of levodopa and dopamine agonists in Parkinson's disease treatment;Tolosa;Neurology,1998

3. Advances in the treatment of Parkinson's disease;Pahwa;Drugs Today,1998

4. Dimeric l-dopa derivatives as potential prodrugs;Di Stefano;Bioorg. Med. Chem. Lett.,2001

5. Comparison of anticonvulsant effects of valproic acid entrapped in positively and negatively charged liposomes in amygdaloid-kindled rats;Mori;Brain Res.,1992

Cited by 50 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. In silico exploration of venlafaxine, a potential non-tricyclic antidepressant in a liposomal formulation for nose-to-brain drug delivery;Drug Development and Industrial Pharmacy;2023-12-25

2. A comprehensive and updated review on the applications of vesicular drug delivery systems in treatment of brain disorders: A shelter against storms;Journal of Drug Delivery Science and Technology;2023-11

3. Advances and Opportunities in Nanoparticle Drug Delivery for Central Nervous System Disorders: A Review of Current Advances;Cureus;2023-08-29

4. Combating Dopaminergic Neurodegeneration in Parkinson’s Disease through Nanovesicle Technology;ACS Chemical Neuroscience;2023-08-03

5. Nanotherapeutic approaches for managing phospholipase-mediated neurodegenerative and metabolic diseases;Phospholipases in Physiology and Pathology;2023